共 126 条
[4]
Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118
[6]
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
[J].
LANCET INFECTIOUS DISEASES,
2021, 21 (02)
:226-240
[7]
Bassetti Matteo, 2018, Drugs Context, V7, P212527, DOI 10.7573/dic.212527